Listed by the USPTO as DEVI, SARVAMANGALA
Tech Center 1600 • Art Units: 1613 1645 1646 1675
This examiner grants 66% of resolved cases
DEVI, SARVAMANGALA is assigned to Tech Center 1600 and Art Unit 1613. The record includes 882 resolved cases, a 65.5% allowance rate, and a median of 1217 days to allowance. The 55.5% interview lift is substantial, indicating that interview planning may be especially important when an application presents issues that are difficult to resolve through written responses alone.
The listed companies are The Brigham and Women's Hospital Inc., The University of British Columbia, and THE GENERAL HOSPITAL Corporation. The listed firms are McNeill PLLC, GREENBERG TRAURIG, LLP (BOS), and HOWSON & HOWSON LLP. The combination of a moderate allowance rate and strong interview association supports proactive prosecution and careful preparation for examiner discussions.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17786121 | METHODS AND COMPOSITIONS FOR DIAGNOSIS OF TUBERCULOSIS | Final Rejection | The Brigham and Women's Hospital, Inc. |
| 17531058 | VACCINE COMPOSITIONS FOR CLOSTRIDIUM DIFFICILE | Final Rejection | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 18714926 | LACTOBACILLI FOR SKIN AGING | Non-Final OA | INTERNATIONAL N&H DENMARK APS |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy65.5% of resolved applications examined by Sarvamangala Devi were allowed (882 resolved cases), compared with 34.0% across Art Unit 1613 over the last five years.
This examiner's interview lift is +55.5 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Sarvamangala Devi took 1,217 days on average from filing to allowance.
Sarvamangala Devi examines applications in Art Unit 1613 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
